Cargando…
Immunotherapy and Transarterial therapy of HCC: What the interventional radiologist needs to know about the changing landscape of HCC treatment?
Hepatocellular carcinoma (HCC) is the fourth most common cancer worldwide and its incidence is increasing in Australia. Transarterial therapy, predominantly transarterial chemoembolization (TACE) but increasingly transarterial radioembolization (TARE), plays an important role in patients with interm...
Autores principales: | Tibballs, Jonathan, Clements, Warren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311219/ https://www.ncbi.nlm.nih.gov/pubmed/35357076 http://dx.doi.org/10.1111/1754-9485.13405 |
Ejemplares similares
-
Immunotherapy-Related Imaging Findings in Patients with Gynecological Malignancies: What Radiologists Need to Know
por: Russo, Luca, et al.
Publicado: (2021) -
Imaging neuroblastoma: what the radiologist needs to know
por: McCarville, M.B.
Publicado: (2011) -
Placental mesenchymal dysplasia: What every radiologist needs to know
por: Mittal, Disha, et al.
Publicado: (2017) -
Chest CT in COVID-19: What the Radiologist Needs to
Know
por: Kwee, Thomas C., et al.
Publicado: (2020) -
What the radiologist needs to know about the diabetic patient
por: Raptis, Athanasios E., et al.
Publicado: (2011)